Employer Economics: The True ROI of Cardiac AI Programs
For employer benefit leaders working through the complex field of health programs, the true measure of a cardiac offering lies not in its marketing narrative,…
For employer benefit leaders working through the complex field of health programs, the true measure of a cardiac offering lies not in its marketing narrative,…
When health plan leaders are trying to figure out which musculoskeletal programs are worth the investment, the real value is found in documented adherence economics,…
If you’re a benefits leader, you’re getting bombarded with claims from cardiac programs. To cut through the noise, especially with AI-powered tools, you have to…
What a Musculoskeletal Program Must Document for Star Ratings A musculoskeletal program, whether AI-powered or otherwise, enters the value-based care arena with a fundamental requirement:…
73% of execs expect AI to boost finances by 2027. Recover 15% lost revenue via AI for no-shows; cut 20% admin costs with concrete strategies.
Providers: Unpack 2026 value-based care myths. Understand patient outcomes, cost-efficiency, and integration for better care delivery.
For self-insured employers and payers, the financial return on digital health investments hinges on preventing high-cost cardiovascular events before they occur. The transition to value-based…
The field of healthcare investment is undergoing a seismic shift, driven by the Centers for Medicare & Medicaid Services (CMS) relentless push towards value-based care.…
The pervasive burden of cardiovascular disease (CVD) on global healthcare systems demands innovative solutions, yet investors are increasingly scrutinizing AI health platforms for tangible, quantifiable…
The relentless financial burden of avoidable cardiac emergency room visits and subsequent hospitalizations represents a critical pain point in the US healthcare system, draining billions…